When PS is appropriate

Example 1 — Pharma — patent licensed to a developing affiliate

Annex II Ch.II · Example 1 · ¶1–4 · Pharma MNE

OECD Guidelines 2022
At a glance
Company A patents a new pharmaceutical formulation after early-stage R&D, then licenses the patent to subsidiary Company S, which performs the subsequent development, obtains regulatory approval, and brings the drug to market. Both contributions are unique and valuable. Which method prices the licence?
Company A (parent)
Early-stage R&D · designed clinical trials · owns patent
patent licence
Company S (subsidiary)
Subsequent development · regulatory approval · enhancement
  1. Company A performs early-stage R&D and designs the clinical trials, leading to a patent on a new formulation.
  2. Company A licenses the patent to its subsidiary Company S.
  3. Company S performs subsequent development and important enhancement functions.
  4. Company S obtains regulatory authorisation and the product is sold in markets worldwide.

Both sides contribute something unique and valuable: Company A's early-stage R&D and the patent, and Company S's later development and enhancement.

Which method best prices the licence?

OECD analysis · Profit split most appropriate
Per Annex II Ch.II · Example 1 (¶4), where both parties make unique and valuable contributions to the licensed intangible, the transactional profit split method is likely to be the most appropriate method. A CUP fails because the contributions are unique (¶2.130). A cost-plus on Company S treats it as a routine developer, which is inconsistent with the delineation that its enhancement functions are themselves unique and valuable.
Key takeaway
Where both the licensor's underlying IP and the licensee's enhancement functions are unique and valuable, a one-sided method on either party leaves the other's contribution unpriced. Profit split is the natural answer.

Related: ¶2.130 (unique and valuable contributions) · Chapter VI (development of intangibles)

Test yourself on this example.Open it in the interactive walkthrough →